Almanac 2014: aortic valve disease

С.M. Otto 

References 

1. Abdel-Wahab M, Zahn R, Gerckens U, et al. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry. Heart 2014;100:1250–6.
2. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790–8.
3. Ali OA, Chapman M, Nguyen TH, et al. Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve. Heart 2014;100:800–5.
4. Aung N, Dworakowski R, Byrne J, et al. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation. Heart 2013;99:1261–6.
5. Barreto-Filho JA, Wang Y, Dodson JA, et al. Trends in aortic valve replacement for elderly patients in the United States, 1999–2011. JAMA 2013;310:2078–85.
6. Borz B, Durand E, Godin M, et al. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 2013;99:860–5.
7. Chambers JB, Ray S, Prendergast B, et al. Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease. Heart 2013;99:1714–16.
8. Chiang YP, Chikwe J, Moskowitz AJ, et al. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA 2014;312:1323–9.
9. Cimadevilla C, Cueff C, Hekimian G, et al. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study. Heart 2013;99:461–7.
10. Detaint D, Michelena HI, Nkomo VT, et al. Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy. Heart 2014;100:126–34.
11. Du DT, McKean S, Kelman JA, et al. Early mortality after aortic valve replacement with mechanical prosthetic vs bioprosthetic valves among medicare beneficiaries: a population-based cohort study. JAMA Intern Med 2014;174:1788–95.
12. Dvir D, Webb JG, Bleiziffer S, et al. Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014;312:162–70.
13. Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. NEnglJ Med 2013;369:1206–14.
14. Eleid MF, Forde I, Edwards WD, et al. Type A aortic dissection in patients with bicuspid aortic valves: clinical and pathological comparison with tricuspid aortic valves. Heart 2013;99:1668–74.
15. Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart 2013;99:396–400.
16. Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 2013;99:914–20.
17. Fairbairn TA, Steadman CD, Mather AN, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart 2013;99:1185–91.
18. Greif M, Lange P, Nabauer M, et al. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart 2014;100:691–5.
19. Iung B, Laouenan C, Himbert D, et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score. Heart 2014;100:1016–23.
20. Jander N, Gohlke-Barwolf C, Bahlmann E, et al. Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis. Heart 2014;100:28–33.
21. Jander N, Hochholzer W, Kaufmann BA, et al. Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Heart 2014;100:1946–53.
22. Kalsch H, Lehmann N, Mahabadi AA, et al. Investigator Group of the Heinz Nixdorf Recall Study. Beyond Framingham risk factors and coronary calcification: does aortic valve calcification improve risk prediction? The Heinz Nixdorf Recall Study. Heart 2014;100:930–7.
23. Khawaja MZ, Williams R, Hung J, et al. Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. Heart 2014;100:1799–803.
24. Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013;310:2069–77.
25. Minners J, Gohlke-Baerwolf C, Kaufmann BA, et al. Adjusting parameters of aortic valve stenosis severity by body size. Heart 2014;100:1024–30.
26. Mylotte D, Lange R, Martucci G, et al. Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve-in-valve procedures. Heart 2013;99:960–7.
27. Nishimura RA, Otto CM, Bonow RO, et al. American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88.
28. Otto CM and Prendergast B. Aortic-valve stenosis—from patients at risk to severe valve obstruction. N Engl J Med 2014;371:744–56.
29. Otto CM. New ACC/AHA valve guidelines: aligning defintions of aortic stenosis severity with treatment recommendations. Heart 2014;100:902–4.
30. Pibarot P. Aortic stenosis: flow matters. Heart 2015;101:5–6.
31. Price J, Toeg H, Lam BK, et al. The impact of prosthesis-patient mismatch after aortic valve replacement varies according to age at operation. Heart 2014;100:1099–106.
32. Ribeiro HB and Rodes-Cabau J. The multiparametric FRANCE-2 risk score: one step further in improving the clinical decision-making process in transcatheter aortic valve implantation. Heart 2014;100:993–5.
33. Shavelle DM. The evolution of transcutaneous aortic valve replacement: moving in the right direction. Heart 2014;100:683–4.
34. Smith JG, Luk K, Schulz CA, et al., Cohorts for H and Aging Research in Genetic Epidemiology Extracoronary Calcium Working Group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA 2014;312:1764–71.
35. Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013;368:503–12.
36. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451–96.